Specimen requirement | Plasma | Urine | |||||||||||||||||||
Adult patient: EDTA tube Number of vials: 1 Minimum blood volume: 3 mL |
Volume: 10 mL 24 Hr urine: U1 bottle |
||||||||||||||||||||
Paediatric patient: Paediatric EDTA tube Number of vials: 3 Minimum blood volume: 3.9 mL |
|||||||||||||||||||||
Authorisation code required | No | No | |||||||||||||||||||
24 Hr available service | No | No | |||||||||||||||||||
Precaution |
Patient should sit for 15 min before and remain in sitting position during blood taking. Refer to protocol for investigation of primary hyperaldosteronism (renin-aldosterone test) for patient preparations. |
||||||||||||||||||||
Method | Liquid chromatography-tandem mass spectrometry | ||||||||||||||||||||
Reference interval |
Plasma:
24 Hr Urine: 2 - 38 nmol/day (Source: local reference interval established from 126 normotensive healthy subjects)
|
||||||||||||||||||||
Clinical indication |
Investigation of hypertension when primary hyperaldosteronism (Conn’s syndrome) is suspected, this is commonly but not invariably associated with hypokalaemia. Documentation of hyperaldosteronism in the investigation of suspected renovascular hypertension. |
||||||||||||||||||||
Result interpretation |
The plasma aldosterone / renin ratio is of greater diagnostic value than either test alone. A high aldosterone / renin ratio suggests a mineralocorticoid abnormality. Elevation of both aldosterone and renin to a similar extent suggests a renal abnormality. The result should be interpreted in consultation with the pathologist. |
||||||||||||||||||||
Measurement of uncertainty | See table. | ||||||||||||||||||||
Frequency of measurement | Biweekly |